Age | ACR Criteria Fulfill Rheumatoid Arthritis
Item
patients ≥18 and <75 years of age that meet the american college of rheumatology (acr) criteria for ra.
boolean
C0001779 (UMLS CUI [1])
C3273747 (UMLS CUI [2,1])
C1550543 (UMLS CUI [2,2])
C0003873 (UMLS CUI [2,3])
Rheumatoid Arthritis
Item
patients with active ra defined as:
boolean
C0003873 (UMLS CUI [1])
Tender joint count | Swollen joint count
Item
1. ≥3 tender joints and ≥3 swollen joints, or
boolean
C0451530 (UMLS CUI [1])
C0451521 (UMLS CUI [2])
Disease activity score DAS28
Item
2. das 28 score >3.1
boolean
C4481729 (UMLS CUI [1])
Infliximab Discontinued | Etanercept Discontinued
Item
patients who are discontinuing treatment with either infliximab or etanercept due to:
boolean
C0666743 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C0717758 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
Lack of Efficacy
Item
1. lack of efficacy, or
boolean
C0235828 (UMLS CUI [1])
Response Incomplete
Item
2. incomplete response.
boolean
C1704632 (UMLS CUI [1,1])
C0205257 (UMLS CUI [1,2])
adalimumab | Therapeutic procedure Patient benefit
Item
patients that, in the opinion of the physician could result beneficiated with the locally approved treatment scheme of adalimumab
boolean
C1122087 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0030705 (UMLS CUI [2,2])
C0814225 (UMLS CUI [2,3])
Infliximab | Etanercept | Therapy change | Adalimumab
Item
those patients who switch from infliximab or etanercept to adalimumab has been done in the last 60 days could be included in the study.
boolean
C0666743 (UMLS CUI [1])
C0717758 (UMLS CUI [2])
C3665894 (UMLS CUI [3])
C1122087 (UMLS CUI [4])
Patients Excluded
Item
the following patients will not be included in the study:
boolean
C0030705 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
Communicable Diseases
Item
patients who have active infections.
boolean
C0009450 (UMLS CUI [1])
Latent Tuberculosis | Induration Thickness | Data Suggestive Medical History | Data Suggestive Chest X-ray
Item
patients with latent tb. for this protocol, evidence of latent tb infection is defined as an induration (not erythema) of 5 mm or greater, 48-72 hrs after placement. any suggested data on the clinical history or chest x-ray.
boolean
C1609538 (UMLS CUI [1])
C0332534 (UMLS CUI [2,1])
C1280412 (UMLS CUI [2,2])
C1511726 (UMLS CUI [3,1])
C0332299 (UMLS CUI [3,2])
C0262926 (UMLS CUI [3,3])
C1511726 (UMLS CUI [4,1])
C0332299 (UMLS CUI [4,2])
C0039985 (UMLS CUI [4,3])
Study Subject Participation Status
Item
patients participating into another study or clinical trial
boolean
C2348568 (UMLS CUI [1])
Condition Interferes with Completion of clinical trial | Condition Study Subject Participation Status At risk
Item
any condition that according to the criteria of the participating physician represents an obstacle for study conduct and/or represents a potential unacceptable risk for patients.
boolean
C0348080 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C2732579 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C2348568 (UMLS CUI [2,2])
C1444641 (UMLS CUI [2,3])